Established in 2018, Stemmetics envisioned utilizing the potential of cells to their highest calibre. We at Stemmetics believe in researching and cell based therapy. Stemmetics aims to set the standard in Regenerative medicine and cell based therapy through research and clinical excellence and responsiveness to the needs of every patient. We aim to be there cognized leader in clinical quality and innovation in health industry.
There are times in human history when quantum leaps occur in our thinking and approach towards the various issues we face as a race.
The world of medicine and healthcare has witnessed one such landmark in the past decade. This is the revolutionary ﬁeld of cell therapy that was awarded the prestigious Nobel Prize in Physiology or Medicine in the year 2012.
This Nobel Prize was awarded jointly to British scientist Sir John B. Gurdon and Japanese stem cell researcher Shinya Yamanaka for the discovery that mature cells can be reprogrammed to become pluripotent.
Stemmetics mission is to administer the safest and most effective stem cell therapies and to deliver the highest quality care through its hospitals.